Columbia University Irving Medical Center/ New York Presbyterian Hospital
Columbia University Irving Medical Center/ New York Presbyterian Hospital
New York, New York, United States8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure | Ventricular Dysfunction, cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-09-09 | NCT06310031 | |
| Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII) | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2026-09-02 | NCT05763407 | |
| NORM-HF Pivotal Study | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-08-25 | NCT07574593 | |
| An Observational Study of Patients With Chronic Liver Disease | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver | Enrolling by invitation | Not stated | 2026-03-03 | NCT05744713 | |
| Enhancing Heart Allograft Function With the OCS Heart System Trial | Heart Transplant | Recruiting | Not applicable | 2026-01-12 | NCT07145515 | |
| US National OCS Heart Perfusion (OHP) Registry | Heart Transplant | Recruiting | Not stated | 2025-10-30 | NCT05915299 | |
| OCS Heart Perfusion Post-Approval Registry | Transplant | Active, not recruiting | Not stated | 2025-10-30 | NCT05047068 | |
| Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Phase 2 | 2025-09-02 | NCT06571708 |